{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:01:25Z","timestamp":1760079685266},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T00:00:00Z","timestamp":1363305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s40256-013-0011-x","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T13:56:19Z","timestamp":1363269379000},"page":"71-78","source":"Crossref","is-referenced-by-count":13,"title":["Optimal Medical Management in Patients with Renovascular Hypertension"],"prefix":"10.1007","volume":"13","author":[{"given":"Olga","family":"Balafa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rigas","family":"Kalaitzidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas C.","family":"Siamopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,15]]},"reference":[{"issue":"25","key":"11_CR1","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.108.191178","volume":"118","author":"KJ Rocha-Singh","year":"2008","unstructured":"Rocha-Singh KJ, Eisenhauer AC, Textor SC, et al. Atherosclerotic Peripheral Vascular Disease Symposium II: intervention for renal artery disease. Circulation. 2008;118(25):2873\u20138.","journal-title":"Circulation"},{"issue":"6","key":"11_CR2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJM200102083440607","volume":"344","author":"RD Safian","year":"2001","unstructured":"Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344(6):431\u201342.","journal-title":"N Engl J Med"},{"issue":"9622","key":"11_CR3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(08)60626-1","volume":"371","author":"K Tullus","year":"2008","unstructured":"Tullus K, Brennan E, Hamilton G, et al. Renovascular hypertension in children. Lancet. 2008;371(9622):1453\u201363.","journal-title":"Lancet"},{"issue":"2","key":"11_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11936-005-0017-z","volume":"7","author":"DP Slovut","year":"2005","unstructured":"Slovut DP, Olin JW. Fibromuscular dysplasia. Curr Treat Options Cardiovasc Med. 2005;7(2):159\u201369.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"4","key":"11_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1755-6686.2008.00043.x","volume":"34","author":"C Chrysochou","year":"2008","unstructured":"Chrysochou C, Kalra PA. Atheromatous renovascular disease: overview and challenges. J Ren Care. 2008;34(4):179\u201390.","journal-title":"J Ren Care"},{"issue":"3","key":"11_CR6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1067\/mva.2002.127351","volume":"36","author":"KJ Hansen","year":"2002","unstructured":"Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36(3):443\u201351.","journal-title":"J Vasc Surg"},{"issue":"7","key":"11_CR7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1445-5994.2003.00396.x","volume":"33","author":"Y Wang","year":"2003","unstructured":"Wang Y, Ho DS, Chen WH, et al. Prevalence and predictors of renal artery stenosis in Chinese patients with coronary artery disease. Intern Med J. 2003;33(7):280\u20135.","journal-title":"Intern Med J"},{"issue":"11","key":"11_CR8","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1681\/ASN.V2111608","volume":"2","author":"MB Harding","year":"1992","unstructured":"Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2(11):1608\u201316.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"11_CR9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1523-1755.1998.00840.x","volume":"53","author":"PJ Ven van de","year":"1998","unstructured":"van de Ven PJ, Beutler JJ, Kaatee R, et al. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int. 1998;53(4):986\u201393.","journal-title":"Kidney Int"},{"issue":"3","key":"11_CR10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/ndt\/gfq026","volume":"25","author":"PA Kalra","year":"2010","unstructured":"Kalra PA. Renal revascularization for heart failure in patients with atherosclerotic renovascular disease. Nephrol Dial Transplant. 2010;25(3):661\u20133.","journal-title":"Nephrol Dial Transplant"},{"issue":"1N","key":"11_CR11","first-page":"46N","volume":"88","author":"JW Olin","year":"1990","unstructured":"Olin JW, Melia M, Young JR, et al. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88(1N):46N\u201351N.","journal-title":"Am J Med"},{"issue":"7","key":"11_CR12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/HJH.0b013e328329bbf4","volume":"27","author":"Q Mast de","year":"2009","unstructured":"de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens. 2009;27(7):1333\u201340.","journal-title":"J Hypertens"},{"issue":"1","key":"11_CR13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/CIRCULATIONAHA.106.637751","volume":"115","author":"H Guo","year":"2007","unstructured":"Guo H, Kalra PA, Gilbertson DT, et al. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation. 2007;115(1):50\u20138.","journal-title":"Circulation"},{"issue":"6","key":"11_CR14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/ndt\/gfg121","volume":"18","author":"JM Ampting van","year":"2003","unstructured":"van Ampting JM, Penne EL, Beek FJ, et al. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant. 2003;18(6):1147\u201351.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"11_CR15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0272-6386(97)90140-2","volume":"29","author":"LU Mailloux","year":"1997","unstructured":"Mailloux LU. Hypertension in the hemodialysis population. Am J Kidney Dis. 1997;29(5):811\u20132.","journal-title":"Am J Kidney Dis"},{"key":"11_CR16","unstructured":"Registry ERA. Annual Report; 2009."},{"issue":"1","key":"11_CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ki.2009.406","volume":"77","author":"PA Kalra","year":"2010","unstructured":"Kalra PA, Guo H, Gilbertson DT, et al. Atherosclerotic renovascular disease in the United States. Kidney Int. 2010;77(1):37\u201343.","journal-title":"Kidney Int"},{"issue":"2","key":"11_CR18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archinte.165.2.207","volume":"165","author":"MS Edwards","year":"2005","unstructured":"Edwards MS, Craven TE, Burke GL, et al. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med. 2005;165(2):207\u201313.","journal-title":"Arch Intern Med"},{"issue":"5","key":"11_CR19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-8703(98)70138-3","volume":"136","author":"JJ Crowley","year":"1998","unstructured":"Crowley JJ, Santos RM, Peter RH, et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J. 1998;136(5):913\u20138.","journal-title":"Am Heart J"},{"issue":"3","key":"11_CR20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ahj.2008.05.013","volume":"156","author":"DG Hackam","year":"2008","unstructured":"Hackam DG, Duong-Hua ML, Mamdani M, et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J. 2008;156(3):549\u201355.","journal-title":"Am Heart J"},{"issue":"9","key":"11_CR21","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1681\/ASN.2005010043","volume":"16","author":"JR Wright","year":"2005","unstructured":"Wright JR, Shurrab AE, Cooper A, et al. Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J Am Soc Nephrol. 2005;16(9):2746\u201353.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"11_CR22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1797.2011.01474.x","volume":"16","author":"J Ritchie","year":"2011","unstructured":"Ritchie J, Chrysochou C, Kalra PA. Contemporary management of atherosclerotic renovascular disease: before and after ASTRAL. Nephrology (Carlton). 2011;16(5):457\u201367.","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"11_CR23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.jhh.1000599","volume":"12","author":"J Webster","year":"1998","unstructured":"Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens. 1998;12(5):329\u201335.","journal-title":"J Hum Hypertens"},{"issue":"3","key":"11_CR24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/01.HYP.31.3.823","volume":"31","author":"PF Plouin","year":"1998","unstructured":"Plouin PF, Chatellier G, Darne B, et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31(3):823\u20139.","journal-title":"Hypertension"},{"issue":"12","key":"11_CR25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-150-12-200906160-00119","volume":"150","author":"L Bax","year":"2009","unstructured":"Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(12):840\u20138. W150-1.","journal-title":"Ann Intern Med"},{"issue":"14","key":"11_CR26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM200004063421403","volume":"342","author":"BC Jaarsveld van","year":"2000","unstructured":"van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342(14):1007\u201314.","journal-title":"N Engl J Med"},{"issue":"20","key":"11_CR27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","volume":"361","author":"K Wheatley","year":"2009","unstructured":"Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953\u201362.","journal-title":"N Engl J Med"},{"issue":"2","key":"11_CR28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/ndt\/18.2.298","volume":"18","author":"NJ Ives","year":"2003","unstructured":"Ives NJ, Wheatley K, Stowe RL, et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant. 2003;18(2):298\u2013304.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"11_CR29","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.CIR.0000027105.02327.48","volume":"106","author":"AR Chade","year":"2002","unstructured":"Chade AR, Rodriguez-Porcel M, Grande JP, et al. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation. 2002;106(9):1165\u201371.","journal-title":"Circulation"},{"issue":"2 Part 2","key":"11_CR30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/01.HYP.37.2.541","volume":"37","author":"LO Lerman","year":"2001","unstructured":"Lerman LO, Nath KA, Rodriguez-Porcel M, et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension. 2001;37(2 Part 2):541\u20136.","journal-title":"Hypertension"},{"issue":"4","key":"11_CR31","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0094-0143(01)80034-3","volume":"28","author":"L Lerman","year":"2001","unstructured":"Lerman L, Textor SC. Pathophysiology of ischemic nephropathy. Urol Clin N Am. 2001;28(4):793\u2013803. ix.","journal-title":"Urol Clin N Am"},{"issue":"6","key":"11_CR32","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206\u201352.","journal-title":"Hypertension"},{"issue":"4","key":"11_CR33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ndt\/gfr496","volume":"27","author":"C Chrysochou","year":"2012","unstructured":"Chrysochou C, Foley RN, Young JF, et al. Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant. 2012;27(4):140\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"11_CR34","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/ndt\/gfh865","volume":"20","author":"A Losito","year":"2005","unstructured":"Losito A, Errico R, Santirosi P, et al. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant. 2005;20(8):1604\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"11_CR35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000101000","volume":"27","author":"A Levin","year":"2007","unstructured":"Levin A, Linas S, Luft FC, et al. Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension. Am J Nephrol. 2007;27(2):212\u201320.","journal-title":"Am J Nephrol"},{"issue":"2","key":"11_CR36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/157016112799304996","volume":"10","author":"RG Kalaitzidis","year":"2012","unstructured":"Kalaitzidis RG, Bakris GL. Pros and cons of aggressive blood pressure lowering in patients with type 2 diabetes. Curr Vasc Pharmacol. 2012;10(2):156\u201361.","journal-title":"Curr Vasc Pharmacol"},{"issue":"7","key":"11_CR37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM198302173080706","volume":"308","author":"DE Hricik","year":"1983","unstructured":"Hricik DE, Browning PJ, Kopelman R, et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med. 1983;308(7):373\u20136.","journal-title":"N Engl J Med"},{"issue":"3 Pt 2","key":"11_CR38","doi-asserted-by":"crossref","first-page":"I63","DOI":"10.1161\/01.HYP.3.3_Pt_2.I63","volume":"3","author":"VJ Dzau","year":"1981","unstructured":"Dzau VJ, Siwek LG, Rosen S, et al. Sequential renal hemodynamics in experimental benign and malignant hypertension. Hypertension. 1981;3(3 Pt 2):I63\u20138.","journal-title":"Hypertension"},{"issue":"6","key":"11_CR39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02938389","volume":"9","author":"SC Textor","year":"2007","unstructured":"Textor SC. Renovascular hypertension in 2007: where are we now? Curr Cardiol Rep. 2007;9(6):453\u201361.","journal-title":"Curr Cardiol Rep"},{"issue":"2","key":"11_CR40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.semnephrol.2003.11.001","volume":"24","author":"AJ Mangrum","year":"2004","unstructured":"Mangrum AJ, Bakris GL. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues. Semin Nephrol. 2004;24(2):168\u201375.","journal-title":"Semin Nephrol"},{"issue":"7","key":"11_CR41","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1046\/j.1532-5415.2002.50321.x","volume":"50","author":"A Ahmed","year":"2002","unstructured":"Ahmed A. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? J Am Geriatr Soc. 2002;50(7):1297\u2013300.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"11_CR42","doi-asserted-by":"crossref","first-page":"622 e1","DOI":"10.1016\/j.ahj.2010.12.006","volume":"161","author":"DJ Kumbhani","year":"2011","unstructured":"Kumbhani DJ, Bavry AA, Harvey JE, et al. Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. Am Heart J. 2011;161(3):622 e1\u2013630 e1.","journal-title":"Am Heart J"},{"issue":"20","key":"11_CR43","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/01.CIR.0000038419.53000.D6","volume":"106","author":"SM Grundy","year":"2002","unstructured":"Grundy SM. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation. 2002;106(20):2526\u20139.","journal-title":"Circulation"},{"key":"11_CR44","unstructured":"Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011;29(23):2432\u201346."},{"key":"11_CR45","doi-asserted-by":"crossref","unstructured":"Navaneethan SD, Pansini F, Perkovic V, et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 2009; (2): CD007784.","DOI":"10.1002\/14651858.CD007784"},{"issue":"6","key":"11_CR46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1159\/000144024","volume":"28","author":"V Tsimihodimos","year":"2008","unstructured":"Tsimihodimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol. 2008;28(6):958\u201373.","journal-title":"Am J Nephrol"},{"issue":"3","key":"11_CR47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000330355","volume":"34","author":"RG Kalaitzidis","year":"2011","unstructured":"Kalaitzidis RG, Elisaf MS. The role of statins in chronic kidney disease. Am J Nephrol. 2011;34(3):195\u2013202.","journal-title":"Am J Nephrol"},{"issue":"2","key":"11_CR48","doi-asserted-by":"crossref","first-page":"c35","DOI":"10.1159\/000107552","volume":"107","author":"CM Cheung","year":"2007","unstructured":"Cheung CM, Patel A, Shaheen N, et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract. 2007;107(2):c35\u201342.","journal-title":"Nephron Clin Pract"},{"issue":"10","key":"11_CR49","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ajh.2008.249","volume":"21","author":"VS Silva","year":"2008","unstructured":"Silva VS, Martin LC, Franco RJ, et al. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. Am J Hypertens. 2008;21(10):1163\u20138.","journal-title":"Am J Hypertens"},{"issue":"11","key":"11_CR50","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1093\/ndt\/gfq269","volume":"25","author":"MT Keddis","year":"2010","unstructured":"Keddis MT, Garovic VD, Bailey KR, et al. Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates. Nephrol Dial Transplant. 2010;25(11):3615\u201322.","journal-title":"Nephrol Dial Transplant"},{"issue":"24","key":"11_CR51","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1056\/NEJMe0804182","volume":"358","author":"RG Dluhy","year":"2008","unstructured":"Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med. 2008;358(24):2630\u20133.","journal-title":"N Engl J Med"},{"key":"11_CR52","doi-asserted-by":"crossref","unstructured":"Standards of Medical Care in Diabetes\u20142012. Diabetes Care. 2012; 35(Supplement 1):S11\u2013S63.","DOI":"10.2337\/dc12-s011"},{"issue":"6","key":"11_CR53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"358","author":"P Gaede","year":"2008","unstructured":"Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580\u201391.","journal-title":"N Engl J Med"},{"issue":"18","key":"11_CR54","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/01.CIR.0000014022.85836.96","volume":"105","author":"SM Grundy","year":"2002","unstructured":"Grundy SM, Garber A, Goldberg R, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. Circulation. 2002;105(18):e153\u20138.","journal-title":"Circulation"},{"issue":"3","key":"11_CR55","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.ajkd.2005.11.027","volume":"47","author":"S Hallan","year":"2006","unstructured":"Hallan S, de Mutsert R, Carlsen S, et al. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis. 2006;47(3):396\u2013405.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"11_CR56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2215\/CJN.03740907","volume":"3","author":"SR Orth","year":"2008","unstructured":"Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients\u2013absence of evidence or evidence of absence? Clin J Am Soc Nephrol. 2008;3(1):226\u201336.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"11_CR57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ehj.2003.10.013","volume":"25","author":"C Patrono","year":"2004","unstructured":"Patrono C, Bachmann F, Baigent C, et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J. 2004;25(2):166\u201381.","journal-title":"Eur Heart J"},{"issue":"7367","key":"11_CR58","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bmj.325.7367.762","volume":"325","author":"AD Blann","year":"2002","unstructured":"Blann AD, Landray MJ, Lip GY. ABC of antithrombotic therapy: an overview of antithrombotic therapy. Bmj. 2002;325(7367):762\u20135.","journal-title":"Bmj"},{"issue":"16","key":"11_CR59","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","volume":"354","author":"DL Bhatt","year":"2006","unstructured":"Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354(16):1706\u201317.","journal-title":"N Engl J Med"},{"issue":"18","key":"11_CR60","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1161\/CIR.0b013e318212bb8b","volume":"123","author":"JL Anderson","year":"2011","unstructured":"Anderson JL, Adams CD, Antman EM, et al. 2011 ACCF\/AHA Focused Update Incorporated Into the ACC\/AHA 2007 Guidelines for the Management of Patients With Unstable Angina\/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123(18):e426\u2013579.","journal-title":"Circulation"},{"issue":"4","key":"11_CR61","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCULATIONAHA.108.788653","volume":"119","author":"AR Chade","year":"2009","unstructured":"Chade AR, Zhu X, Lavi R, et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation. 2009;119(4):547\u201357.","journal-title":"Circulation"},{"issue":"2","key":"11_CR62","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/HYPERTENSIONAHA.110.164202","volume":"57","author":"LC Matavelli","year":"2011","unstructured":"Matavelli LC, Huang J, Siragy HM. Angiotensin AT receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension. 2011;57(2):308\u201313.","journal-title":"Hypertension"},{"issue":"1","key":"11_CR63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ahj.2005.09.011","volume":"152","author":"CJ Cooper","year":"2006","unstructured":"Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006;152(1):59\u201366.","journal-title":"Am Heart J"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-013-0011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-013-0011-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-013-0011-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T13:07:38Z","timestamp":1644584858000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-013-0011-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,15]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s40256-013-0011-x","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,15]]}}}